Inge Ubink

729 total citations
19 papers, 459 citations indexed

About

Inge Ubink is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Inge Ubink has authored 19 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Inge Ubink's work include Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Inge Ubink is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Inge Ubink collaborates with scholars based in Netherlands, Germany and United States. Inge Ubink's co-authors include Onno Kranenburg, Inne H.M. Borel Rinkes, Sjoerd G. Elias, Miangela M. Laclé, Wilhelmina M. U. van Grevenstein, Daniëlle Raats, Klaas M. Govaert, André Verheem, Roel Goldschmeding and Niek A. Peters and has published in prestigious journals such as Gastroenterology, JNCI Journal of the National Cancer Institute and Annals of Surgery.

In The Last Decade

Inge Ubink

19 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Ubink Netherlands 14 241 145 139 97 93 19 459
Gen Nishikawa Japan 8 177 0.7× 153 1.1× 117 0.8× 114 1.2× 33 0.4× 14 444
Astrid Schott Germany 6 171 0.7× 213 1.5× 73 0.5× 33 0.3× 67 0.7× 8 422
Katherine J. Blair United States 11 128 0.5× 138 1.0× 64 0.5× 84 0.9× 24 0.3× 17 389
S. Loibl Germany 10 254 1.1× 93 0.6× 146 1.1× 96 1.0× 49 0.5× 30 516
Annika Ålgars Finland 14 393 1.6× 147 1.0× 122 0.9× 111 1.1× 85 0.9× 34 657
Zebing Liu China 13 190 0.8× 249 1.7× 37 0.3× 125 1.3× 113 1.2× 38 514
Takako Nirei Japan 9 284 1.2× 97 0.7× 85 0.6× 103 1.1× 20 0.2× 13 435
Jianjun Yang China 8 215 0.9× 141 1.0× 66 0.5× 126 1.3× 17 0.2× 13 389
Nuria Rodrı́guez-Salas Spain 13 307 1.3× 140 1.0× 67 0.5× 114 1.2× 81 0.9× 32 485
Motonori Futatsugi Japan 9 246 1.0× 293 2.0× 96 0.7× 79 0.8× 75 0.8× 13 526

Countries citing papers authored by Inge Ubink

Since Specialization
Citations

This map shows the geographic impact of Inge Ubink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Ubink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Ubink more than expected).

Fields of papers citing papers by Inge Ubink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Ubink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Ubink. The network helps show where Inge Ubink may publish in the future.

Co-authorship network of co-authors of Inge Ubink

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Ubink. A scholar is included among the top collaborators of Inge Ubink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Ubink. Inge Ubink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Küçükköse, Emre, Niek A. Peters, Inge Ubink, et al.. (2022). KIT promotes tumor stroma formation and counteracts tumor-suppressive TGFβ signaling in colorectal cancer. Cell Death and Disease. 13(7). 617–617. 10 indexed citations
2.
Peters, Niek A., Inge Ubink, Joyce van Kuik, et al.. (2022). Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study. Frontiers in Oncology. 12. 969855–969855. 17 indexed citations
3.
Ubink, Inge, Henk M.W. Verheul, Johannes H. W. de Wilt, et al.. (2022). In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival. Annals of Surgical Oncology. 29(8). 5256–5262. 1 indexed citations
4.
Sacchetti, Andrea, Miriam Teeuwssen, Rosalie Joosten, et al.. (2021). Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer. eLife. 10. 43 indexed citations
5.
Ubink, Inge, Ana C.F. Bolhaqueiro, Sjoerd G. Elias, et al.. (2019). Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy. British journal of surgery. 106(10). 1404–1414. 74 indexed citations
6.
Elias, Sjoerd G., Kari Trumpi, Anne Trinh, et al.. (2018). Increased Levels of Oxidative Damage in Liver Metastases Compared with Corresponding Primary Colorectal Tumors. American Journal Of Pathology. 188(10). 2369–2377. 12 indexed citations
7.
Ubink, Inge, Pétur Snæbjörnsson, Niels F. M. Kok, et al.. (2018). Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases. British journal of surgery. 105(2). e204–e211. 59 indexed citations
8.
Vellinga, Thomas T., Onno Kranenburg, Inge Ubink, et al.. (2017). Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis. Annals of Surgery. 266(5). 765–771. 22 indexed citations
9.
Ubink, Inge, Haiko J. Bloemendal, Sjoerd G. Elias, et al.. (2017). Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT). BMC Cancer. 17(1). 282–282. 13 indexed citations
10.
Trumpi, Kari, Inge Ubink, Anne Trinh, et al.. (2017). Neoadjuvant chemotherapy affects molecular classification of colorectal tumors. Oncogenesis. 6(7). e357–e357. 31 indexed citations
11.
Borovski, Tijana, Thomas T. Vellinga, Jamila Laoukili, et al.. (2016). Inhibition of RAF1 kinase activity restores apicobasal polarity and impairs tumour growth in human colorectal cancer. Gut. 66(6). 1106–1115. 24 indexed citations
12.
Weeber, Fleur, Sander Bins, Christa G.M. Gadellaa-van Hooijdonk, et al.. (2016). The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies. Annals of Oncology. 27(8). 1638–1643. 14 indexed citations
13.
Ubink, Inge, Sjoerd G. Elias, Cathy B. Moelans, et al.. (2016). A Novel Diagnostic Tool for Selecting Patients With Mesenchymal-Type Colon Cancer Reveals Intratumor Subtype Heterogeneity. JNCI Journal of the National Cancer Institute. 109(7). 25 indexed citations
14.
Ubink, Inge, et al.. (2016). A potential role for CCN2/CTGF in aggressive colorectal cancer. Journal of Cell Communication and Signaling. 10(3). 223–227. 28 indexed citations
15.
Ubink, Inge, Maarten W. Nijkamp, Eelco F. J. Meijer, et al.. (2016). Surgical and Oncologic Outcomes After Major Liver Surgery and Extended Hemihepatectomy for Colorectal Liver Metastases. Clinical Colorectal Cancer. 15(4). e193–e198. 14 indexed citations
16.
Fátrai, Szabolcs, Inge Ubink, Klaas M. Govaert, et al.. (2015). Maintenance of Clonogenic KIT+ Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells. Gastroenterology. 149(3). 692–704. 31 indexed citations
17.
Ubink, Inge, Sylvia van der Horst, Jurjen J. Boonstra, et al.. (2015). Safety, Efficacy, and Long-Term Follow-Up Evaluation of Perioperative Epirubicin, Cisplatin, and Capecitabine Chemotherapy in Esophageal Resection for Adenocarcinoma. Annals of Surgical Oncology. 22(5). 1555–1563. 13 indexed citations
18.
Hoogstraat, Marlous, Inge Ubink, Nicolle Besselink, et al.. (2014). Detailed imaging and genetic analysis reveal a secondary BRAFL505H resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib. Pigment Cell & Melanoma Research. 28(3). 318–323. 21 indexed citations
19.
Ubink, Inge, Pieter C. van der Sluis, M.E.I. Schipper, et al.. (2013). Adding Preoperative Radiotherapy Plus Cetuximab to Perioperative Chemotherapy for Resectable Esophageal Adenocarcinoma: A Single-Center Prospective Phase II Trial. The Oncologist. 19(1). 32–33. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gen Nishikawa Breakdown of academic impact, for papers by Astrid Schott Breakdown of academic impact, for papers by Katherine J. Blair Breakdown of academic impact, for papers by S. Loibl Breakdown of academic impact, for papers by Annika Ålgars Breakdown of academic impact, for papers by Zebing Liu Breakdown of academic impact, for papers by Takako Nirei Breakdown of academic impact, for papers by Jianjun Yang Breakdown of academic impact, for papers by Nuria Rodrı́guez-Salas Breakdown of academic impact, for papers by Motonori Futatsugi
Rankless by CCL
2026